Skip to main content
Livermore
Livermore
ZHEN

LPL Financial LLC

SEC CIK
0001403438
Latest filing
Aug 7, 2026

SUPN holding history

Supernus Pharmaceuticals, Inc. in every 13F filed by LPL Financial LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SUPN overviewAll 13F holders of SUPNFull Q2 2026 holdings

Shares (Q2 2026)
10,697
Value
$497.5K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of SUPN by LPL Financial LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,697$497.5K<0.1%−529−4.7%ReducedHolders
Q1 202611,226$580.3K<0.1%−6,265−35.8%ReducedHolders
Q4 202517,491$869.3K<0.1%+10,279+142.5%AddedHolders
Q3 20257,212$344.7K<0.1%−9,270−56.2%ReducedHolders
Q2 202516,482$519.5K<0.1%+429+2.7%AddedHolders
Q1 202516,053$525.7K<0.1%+3,312+26.0%AddedHolders
Q4 202412,741$460.7K<0.1%+2,029+18.9%AddedHolders
Q3 202410,712$334.0K<0.1%+552+5.4%AddedHolders
Q2 202410,160$271.8K<0.1%+2,739+36.9%AddedHolders
Q1 20247,421$253.1K<0.1%+7,421NewHolders
Q3 20230$00.0%−7,406−100.0%Sold outHolders
Q2 20237,406$222.6K<0.1%−1,253−14.5%ReducedHolders
Q1 20238,659$313.7K<0.1%−795−8.4%ReducedHolders
Q4 20229,454$337.2K<0.1%−9,474−50.1%ReducedHolders
Q3 202218,928$641.0K<0.1%−4,591−19.5%ReducedHolders
Q2 202223,519$680.0K<0.1%+1,883+8.7%AddedHolders
Q1 202221,636$699.0K<0.1%+64+0.3%AddedHolders
Q4 202121,572$629.0K<0.1%+1,754+8.9%AddedHolders
Q3 202119,818$529.0K<0.1%+1,370+7.4%AddedHolders
Q2 202118,448$568.0K<0.1%−2,371−11.4%ReducedHolders
Q1 202120,819$545.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.